Eiger BioPharmaceuticals, Inc. Eiger BioPharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc.

EIGR

Ранг среди акций #36445
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company... Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and bringing to market targeted therapies for rare and ultra-rare diseases across the United States and internationally. Its primary investigational drug, Lonafarnib, an orally administered small molecule, is currently undergoing Phase III clinical trials for the treatment of hepatitis delta virus (HDV) infection. Other promising candidates in its portfolio include Lambda, which has completed Phase II clinical trials and is designed to target type III interferon receptors; Lonafarnib, also being evaluated for progeria and progeroid laminopathies; and Avexitide, an agent for congenital hyperinsulinism that has also successfully concluded Phase II studies for post-bariatric hypoglycemia. Established in 2008, Eiger BioPharmaceuticals, Inc. maintains its headquarters in Palo Alto, California.
Цена акции
$1.73
Последняя синхронизация: 2025-06-17
Рыночная капитализация
$2.55M
Изменение (1 день)
-0.29%
Изменение (1 год)
-79.71%
Страна
US
Торговля Eiger BioPharmaceuticals, Inc. (EIGR)

Категория

Healthcare
История дроблений акций Eiger BioPharmaceuticals, Inc. (EIGR)
Акции Eiger BioPharmaceuticals, Inc. (символ: EIGR) прошли через 2 дроблений.
Последнее дробление произошло Jan 08, 2024.
Одна акция EIGR, купленная до Mar 23, 2016, сейчас соответствует 0.0022222222222222 акциям EIGR.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
2024-01-08 1:30 x0.033333333333333 x0.0022222222222222
2016-03-23 1:15 x0.066666666666667 x0.066666666666667
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL